Becton Dickinson (BDX) Cash from Investing Activities (2009 - 2026)

Becton Dickinson (BDX) reported Cash from Investing Activities of -$139.0 million for Q1 2026, down 4.51% year-over-year from -$145.6 million in Q1 2025, and up 24.04% quarter-over-quarter from -$183.0 million in Q4 2025.

Becton Dickinson (BDX) Cash from Investing Activities (2009 - 2026) Analysis & Trends

Becton Dickinson (BDX) has 18 years of Cash from Investing Activities data on file, last reported at -$139.0 million in Q1 2026.

  • Cash from Investing Activities for Q1 2026 came in at -$139.0 million, down 4.51% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.2 billion (up 70.85% YoY), and the FY2025 annual result was -$818.0 million, up 85.17% from the prior year.
  • Cash from Investing Activities advanced to -$139.0 million in Q1 2026 per BDX's latest filing, from -$183.0 million in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $204.0 million in Q4 2024 and troughed at -$3.9 billion in Q3 2024.
  • A 5-year average of -$582.8 million and a median of -$288.0 million in 2024 frame the typical range for Cash from Investing Activities.
  • On a YoY basis, Cash from Investing Activities climbed as much as 187.55% in 2024 and fell as far as 2973.72% in 2024.
  • A 5-year view of Cash from Investing Activities shows it stood at -$291.0 million in 2022, then grew by 19.93% to -$233.0 million in 2023, then soared by 187.55% to $204.0 million in 2024, then slumped by 189.71% to -$183.0 million in 2025, then climbed by 24.04% to -$139.0 million in 2026.
  • Business Quant data shows BDX's Cash from Investing Activities at -$139.0 million in Q1 2026, -$183.0 million in Q4 2025, and -$494.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing (Qtr)
1 Intuitive Surgical 148.09 Bn 143.69 Bn 1.83 Bn -914.50 Mn
2 Becton Dickinson 41.00 Bn 39.99 Bn 2.15 Bn -139.00 Mn
3 Medline 30.38 Bn 36.22 Bn 1.84 Bn -96.00 Mn
4 Resmed 28.22 Bn 26.56 Bn 890.98 Mn -58.03 Mn
5 West Pharmaceutical Services 23.72 Bn 23.19 Bn 296.40 Mn -42.70 Mn
6 Solventum 13.33 Bn 13.33 Bn 1.10 Bn -77.00 Mn
7 Cooper Companies 13.12 Bn 12.99 Bn 735.40 Mn -90.00 Mn
8 Align Technology 12.86 Bn 11.80 Bn 736.59 Mn -131.58 Mn
9 Baxter International 10.51 Bn 8.47 Bn 891.00 Mn -133.00 Mn
10 Aptargroup 7.72 Bn 7.52 Bn 351.91 Mn -65.10 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -139.00 Mn
Mar 31, 2026 -139.00 Mn
Dec 31, 2025 -183.00 Mn
Dec 31, 2025 -183.00 Mn
Sep 30, 2025 -494.00 Mn
Sep 30, 2025 -494.00 Mn
Jun 30, 2025 -395.00 Mn
Jun 30, 2025 -395.00 Mn
Mar 31, 2025 -133.00 Mn
Mar 31, 2025 -133.00 Mn
Dec 31, 2024 204.00 Mn
Dec 31, 2024 204.00 Mn
Sep 30, 2024 -3.94 Bn
Sep 30, 2024 -3.94 Bn
Jun 30, 2024 -288.00 Mn
Jun 30, 2024 -288.00 Mn
Mar 31, 2024 -1.06 Bn
Mar 31, 2024 -1.06 Bn
Dec 31, 2023 -233.00 Mn
Dec 31, 2023 -233.00 Mn